Shilpa Hattangadi, MD

Assistant Professor of Pediatrics (Hematology / Oncology) and of Pathology; Assistant Professor, Pathology

Departments & Organizations

Pediatrics: Hematology & Oncology

Pathology: Experimental Pathology Graduate Program

Cancer Center: Genomics, Genetics, and Epigenetics | Pediatric Hematology & Oncology Program

Faculty Research

Stem Cell Center, Yale

Yale Combined Program in the Biological and Biomedical Sciences (BBS): Molecular Cell Biology, Genetics and Development: Cell Biology; Development; Human Disease; Imaging (super-resolution); Nuclear Dynamics; Proteomics; Regenerative Biology /Stem Cells | Molecular Medicine, Pharmacology, and Physiology: Cancer Biology and Therapeutics; Genetics, Genomics and Proteomics; Hematology, Vascular Biology and Inflammation; Human Disease Pathology, Physiology and Intervention; Protein Sorting and Trafficking; Stem Cell Biology; Systems Biology

Yale Medicine

Office of Cooperative Research


Shilpa Hattangadi has a background in Electrical Engineering and Computer Science from her undergraduate at MIT. Her postdoctoral work in Harvey Lodish's lab spurred an interest in applying fundamental molecule biology to intriguing questions of red blood cell development. Her initial work on the dynamics of chromatin modifications during erythroid transcription brought her focus to nuclear development, and her laboratory now centers on the dynamics of chromatin during terminal erythroid differentiation, specifically chromatin condensation and enucleation, which is specific to mammalian red cell development.

Education & Training

MD Duke University Medical Center, Medicine (1999)
BS Massachusetts Institute of Technology, Electrical Engineering/Biology (1995)
Postdoctoral Fellow Whitehead Institute for Biomedical Research
Fellowship Boston Children's Hospital/Dana Farber Cancer Center
Residency Johns Hopkins Hospital
Board Certification AB of Pediatrics, Pediatric Hematology-Oncology (2006)

Edit this profile

Contact Info

Shilpa Hattangadi, MD
Patient Care Location
Pediatric Hematology & OncologySmilow Cancer Hospital at Yale - New Haven
35 Park Street, Ste 7th floor

New Haven, CT 06511
View on map...
Mailing Address
Pediatric Hematology-Oncology
333 Cedar Street

New Haven, CT 06520
Erythroid Terminal Differentiation

A set number of characteristic cell divisions (3 in mouse, 4 in humans) from the progenitor to the final erythroblast result in decreased cell size. A distinct expression program results in hemoglobin production, making the cytoplasm more eosinophilic. Nuclear condensation ensues and culminates in enucleation only in mammals. We study this last step of terminal erythropoiesis.